semaglutide frequent urination Ozempic: is a GLP-1 receptor agonist used for type 2 diabetes and cardiovascular risk reduction in selected patients, commonly causing nausea, vomiting, diarrhea, constipation, abdominal pain, reduced appetite, and weight loss Is 'Ozempic Butt' A Real

Mills JL, Knopp RH, Simpson JL, et al

The public booking flow does not ask a BMI or eligibility-gating weight question, does not collect a medical history, does not ask about current medications or allergies, does not include a dedicated MEN-2 or medullary thyroid cancer family-history screen, does not ask the eating-disorder question, does not check pregnancy or breastfeeding status, does not include a validated mental-health instrument, and does not ask about substance or alcohol use

More participants reported moderate nausea, and some experienced vomiting for the first time

Studies using Campbell rats with hereditary retinal degeneration confirmed these findings, showing Epithalon treatment maintained rod photoreceptor structure and prevented progressive retinal cell death

By type of product, the semaglutide section had taken about 42.5% of the market share by 2025